XNCR FY 2015 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M+191.6% YoY

Gross Profit

-$6M-23.0% margin

Operating Income

-$18M-66.1% margin

Net Income

-$18M-63.4% margin

EPS (Diluted)

$-0.45

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$23M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$207M

Total Liabilities

$44M

Stockholders' Equity

$162M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$10M	+191.6%
Gross Profit	-$6M	-$9M	+29.1%
Operating Income	-$18M	-$16M	-11.4%
Net Income	-$18M	-$16M	-7.1%